Synopsis of recent research by authors named "Wenguang Fu"
- Wenguang Fu's recent research primarily focuses on cancer pathology, emphasizing innovative therapeutic targets and mechanisms, particularly in hepatocellular carcinoma (HCC) and pancreatic ductal adenocarcinoma (PDAC), through studies involving gene expression and redox signaling pathways.
- Notable findings include the identification of new prognostic biomarkers and therapeutic targets such as FXR, MRP-1, and the ferroptosis-related LINC02535/has-miR-30c-5p/EIF2S1 axis, which interplay with cancer progression and immune infiltration.
- Fu's studies also address the complex relationship between oxidative stress and chronic diseases, exploring the metabolic and inflammatory pathways contributing to conditions like atherosclerosis, liver injury, and cancer development.
